Hassan Namir J, Barclay A Neil, Brown Marion H
Sir William Dunn School of Pathology, University of Oxford, Oxford, GB.
Eur J Immunol. 2004 Apr;34(4):930-40. doi: 10.1002/eji.200424856.
The T cell surface glycoprotein, CD6 binds CD166 in the first example of an interaction between a scavenger receptor cysteine-rich domain and an immunoglobulin-like domain. We report that in human these proteins interact with a K(D) =0.4-1.0 microM and K(off) > or =0.4-0.63 s(-1), typical of many leukocyte membrane protein interactions. CD166 also interacts in a homophilic manner but with around 100-fold lower affinity (K(D) =29-48 microM and K(off) > or = 5.3 s(-1)). At concentrations, that will block the CD6/CD166 interaction, soluble monomeric CD6 and CD166 inhibit antigen-specific human T cell responses. This is consistent with extracellular engagement between CD6 and CD166 being required for an optimal immune response.
T细胞表面糖蛋白CD6与CD166结合,这是富含半胱氨酸的清道夫受体结构域与免疫球蛋白样结构域之间相互作用的首个实例。我们报道,在人类中,这些蛋白以K(D)=0.4 - 1.0微摩尔、K(off)≥0.4 - 0.63秒(-1)的亲和力相互作用,这是许多白细胞膜蛋白相互作用的典型特征。CD166也以同源方式相互作用,但其亲和力低约100倍(K(D)=29 - 48微摩尔,K(off)≥5.3秒(-1))。在能够阻断CD6/CD166相互作用的浓度下,可溶性单体CD6和CD166会抑制抗原特异性人类T细胞反应。这与最佳免疫反应需要CD6和CD166之间的细胞外结合相一致。